Yuanhe Chencun secures three consecutive wins on the STAR Market—Junshi Biosciences and two other companies successfully pass the review.

2020-04-03

Recently, three companies from the mother fund portfolio managed by Yuanhe Chencun successfully passed the review on the STAR Market: Shanghai Junshi Biosciences Co., Ltd. (hereafter referred to as "Junshi Biosciences"), Beijing Shenzhou Cell Biotechnology Group Co., Ltd. (hereafter referred to as "Shenzhou Cell"), and Beijing Tianzhihang Medical Technology Co., Ltd. (hereafter referred to as "Tianzhihang").

Good news from Yuanhe Bingsheng Mother Fund—Douyu successfully lists on the U.S. stock market.

2019-07-17

On July 17, 2019, Douyu Network Technology Co., Ltd. (hereinafter referred to as "Douyu"), a project directly invested in by Yuanhe Bingsheng, was successfully listed on the NASDAQ in the United States, trading under the ticker symbol "DOYU." On its first day of trading, the company’s market capitalization exceeded $3.7 billion.

Great news for Yuanhe Boseng Mother Fund—Lanqi Technology has successfully passed the review on the STAR Market.

2019-06-13

On June 13, 2019, Lanqi Technology Co., Ltd. (hereinafter referred to as "Lanqi Technology"), a project directly invested in by Yuanhe Bingsheng, successfully passed the review of the Science and Technology Innovation Board Listing Committee.

Great news from the National Innovation Yuanhe Fund—Yunji has been listed on the NASDAQ in the U.S.!

2019-05-03

On May 3, 2019, Yunji, an e-commerce platform backed by Zhongding Fund III—a fund under Guochuang Yuanhe Mother Fund—officially listed on the NASDAQ in the U.S., with the stock ticker symbol YJ.

Great news from the National Innovation Yuanhe Fund—DeepSec Technology successfully listed on the A-share market.

2019-04-12

On April 12, Hangzhou Dip Technology Co., Ltd., an investment project of Fangguang Phase I Fund, a sub-fund under the National Innovation Yuanhe Mother Fund, made its debut on the ChiNext Board, with stock code "300768."